Vixen Pharmaceuticals

Vixen Pharmaceuticals Acquired By Aclaris Therapeutics

March 28, 2016 /

Well you guys asked for it, right? An established pharmaceutical company has acquired the rights to Angela Christiano’s hair growth research involving JAK inhibitors. Aclaris Therapeutics has entered into an agreement with Vixen to acquire all of the stock of Vixen Pharmaceuticals. For those unaware, Vixen Pharma is the small startup company that Christiano founded…

Read More

JAK Inhibitors Show Great Potential as a Hair Loss Treatment

October 25, 2015 /

Angela Christiano is up to it again, and the online hair world is very thankful. It was just a little over a year ago when the internet was ablaze with the news that Dr. Angela Christiano and her colleagues were studying the pharmaceutical drug ruxolitinib in cases of alopecia areata. Like tofacitinib, ruxolitinib is a…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.